Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
The University only accepts and considers applications submitted online for the post above via the CUHK career site. For more information and to apply online, please visit http://career.cuhk.edu.hk.
-
research group under the national competitive funding programme “My First Research Team” . This programme is designed to accelerate the transition to research independence and to support the development
-
flagship research programme that defines the future of metabolic medicine, leveraging Singapore's unique position as a global biomedical hub. As a senior faculty member reporting to the Dean and Vice-Dean
-
program leveraging Artificial Intelligence (AI) and computational approaches to accelerate mechanistic understanding, target identification, and therapeutic development, as part of the ENACT program (https
-
cutting-edge research in areas such as pattern recognition, automation science, complex systems, AI for Science, robotics, machine learning, computer vision, natural language processing, biometrics, medical
-
-01-01), together with leading researchers across Europe. You will become part of a cohort of 13 PhD students jointly trained in modern biophysical techniques involving both computational and
-
multidisciplinary environment, with opportunities for collaboration within the School to advance its research mission. The candidate will establish and sustain an independent, externally funded research program
-
Track - Clinical responsibilities may include providing outstanding clinical care and productivity in program development. Clinical care will be provided in the 100-bed Level IV Neonatal/Infant Intensive
-
280 international programs of different types. The University has currently established four world-classdisciplinary groups: computer data science, materials chemistry, biomedical science, and economics
-
innovative computational methods for genome sequencing data to advance our understanding of human health and disease (e.g., cancer and neurodegenerative disorders), with a current focus on genomic repeats